IL18 and neoplasm: These findings open an avenue for the generation of increased numbers of γδ T cells and approve/recommend the adoptive transfer of IL-2/IL-12/IL-18-stimulated γδ T cells for an unbiased clear boost of anti-tumor activity of γδ T cells in clinical settings.